JPS53127832A - Antiphkogistics for oral administration containing thiaprostaglandins - Google Patents

Antiphkogistics for oral administration containing thiaprostaglandins

Info

Publication number
JPS53127832A
JPS53127832A JP4045877A JP4045877A JPS53127832A JP S53127832 A JPS53127832 A JP S53127832A JP 4045877 A JP4045877 A JP 4045877A JP 4045877 A JP4045877 A JP 4045877A JP S53127832 A JPS53127832 A JP S53127832A
Authority
JP
Japan
Prior art keywords
oral administration
antiphkogistics
thiaprostaglandins
administration containing
antiphlogistic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4045877A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6241207B2 (enExample
Inventor
Keiji Komoriya
Seiji Kurozumi
Takeshi Yu
Makiko Kobayashi
Kenji Hoshina
Hiroyuki Kawashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP4045877A priority Critical patent/JPS53127832A/ja
Publication of JPS53127832A publication Critical patent/JPS53127832A/ja
Publication of JPS6241207B2 publication Critical patent/JPS6241207B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP4045877A 1977-04-11 1977-04-11 Antiphkogistics for oral administration containing thiaprostaglandins Granted JPS53127832A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4045877A JPS53127832A (en) 1977-04-11 1977-04-11 Antiphkogistics for oral administration containing thiaprostaglandins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4045877A JPS53127832A (en) 1977-04-11 1977-04-11 Antiphkogistics for oral administration containing thiaprostaglandins

Publications (2)

Publication Number Publication Date
JPS53127832A true JPS53127832A (en) 1978-11-08
JPS6241207B2 JPS6241207B2 (enExample) 1987-09-02

Family

ID=12581192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4045877A Granted JPS53127832A (en) 1977-04-11 1977-04-11 Antiphkogistics for oral administration containing thiaprostaglandins

Country Status (1)

Country Link
JP (1) JPS53127832A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108065A (en) * 1980-12-26 1982-07-05 Teijin Ltd 7-thiaprostaglandin e1 derivative, its preparation, and blood platelet coagulation inhibiting agent containing said derivative as active component
WO2000025771A1 (en) * 1998-11-04 2000-05-11 Synphora Ab Method for preventing increased iridial pigmentation during prostaglandin treatment
WO2003037373A1 (en) * 2001-10-31 2003-05-08 Medical Research Council Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108065A (en) * 1980-12-26 1982-07-05 Teijin Ltd 7-thiaprostaglandin e1 derivative, its preparation, and blood platelet coagulation inhibiting agent containing said derivative as active component
WO2000025771A1 (en) * 1998-11-04 2000-05-11 Synphora Ab Method for preventing increased iridial pigmentation during prostaglandin treatment
WO2003037373A1 (en) * 2001-10-31 2003-05-08 Medical Research Council Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer

Also Published As

Publication number Publication date
JPS6241207B2 (enExample) 1987-09-02

Similar Documents

Publication Publication Date Title
JPS51135900A (en) Method for prod uction of the stable sodium percarbonate
JPS53127832A (en) Antiphkogistics for oral administration containing thiaprostaglandins
JPS5218610A (en) Structure of vibration-proof track
JPS5218609A (en) Structure of vibration-prof track
JPS52154528A (en) Remedy for glaucoma
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS5423132A (en) Analgesic composition
JPS51131964A (en) Filter device
JPS5221561A (en) Gear transformation device
JPS52134395A (en) Led display device
JPS5248897A (en) Device for fitting tooth surfaces or the like
JPS53149707A (en) Am-ssb common-use transmitter-receiver
JPS52100483A (en) Isoleucomycin a5
JPS5344634A (en) Carcinostatic agent
JPS53124073A (en) Sealing unit for glass sealing type semiconductor device
JPS5346937A (en) Preparation of n-p-aminobenzoyl-n,-p-aminourea
JPS52128234A (en) Anticarcinogens
JPS51124036A (en) Bathroom in a kit form
JPS52118453A (en) Indene derivatives
JPS53127833A (en) Novel analgesic antiphlogistic agent
JPS5432634A (en) Medicines for peptic ulcer
JPS5270574A (en) Dust-entangling-proof for stoker
JPS5362839A (en) Combined analgesic antiphlogistics
JPS5312878A (en) Preparation of cyanopyrazinecarboxyamide and its preparation
JPS5264990A (en) Weight converting circuit